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Abstract
Over- and undertreatment harm patients and society and confound other healthcare
quality measures. Despite a growing body of research covering specific conditions,
we lack tools to systematically detect and measure over- and undertreatment in hos-
pitals. We demonstrate a test used to monitor over- and undertreatment in Dutch
hospitals, and illustrate its results applied to the aggregated administrative treatment
data of 1,836,349 patients at 89 hospitals in 2013. We employ a random effects model
to create risk-adjusted funnel plots that account for natural variation among hospitals,
allowing us to estimate a measure of overtreatment and undertreatment when hospi-
tals fall outside the control limits. The results of this test are not definitive, findings
were discussed with hospitals to improve the model and to enable the hospitals to
make informed treatment decisions.
1 INTRODUCTION
Undertreatment and overtreatment are well-documented problems of health care quality.
While the negative consequences of undertreatment for patients are obvious, overtreat-
ment can also harm patients (FRANKS ET AL. 1992, BANGMA ET AL. 2007, ESSERMAN
ET AL. 2013). Moreover, overtreatment increases the costs of health care to society at large.
By one estimate, between 6% and 8% of total spending on health care in the United States
in 2011 was due to overtreatment, amounting to between $18 and $44 billion (BERWICK &
HACKBARTH 2012). Eliminating these costs is generally a preferable alternative to other
types of cutbacks such as lowering insurance coverage.
Apart from being harmful in their own right, over- and undertreatment also affect
subsequent quality evaluation measures of specific negative outcomes. In-hospital mor-
tality, readmission, and long-stay rates all depend on the prior question of how easily a
person becomes a patient at all. For example, if a hospital diagnoses additional patients
that would otherwise not have been treated, these ‘light’ patients will lower its mortality,
readmission, and long-stay rates. Conversely, if a hospital, for whatever reason, is more
disinclined to treat people with a particular diagnosis, it may be the more severe cases
that remain. Such differences will impact quality evaluations that compare health care
providers (such as COORY ET AL. 2008, BARDSLEY ET AL. 2009, JARMAN ET AL. 2010).
Clearly we want to be able to detect and measure under- and overtreatment. Several
studies have examined overtreatment of particular diagnoses, especially prostate cancer
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(see BRATT 2006, BANGMA ET AL. 2007, HEIJNSDIJK ET AL. 2009 and references therein),
but also thyroid cancer (LEE ET AL. 2012), cancer in general (ESSERMAN ET AL. 2013),
hypertension (FURBERG ET AL. 1994), asthma (CAUDRI ET AL. 2011), diabetes mellitus
(SUTIN 2010), and even childbirth (ALBERS 2005). But to our knowledge, we lack more
general approaches of measuring over- and undertreatment.
This article demonstrates a test that is used to monitor both over- and undertreatment
across diagnoses. Recognizing that natural variation between providers can cause signif-
icant differences, we use funnel plots based on random effects models (SPIEGELHALTER
2005, OHLSSEN ET AL. 2005) of casemix-adjusted incidence rates. We apply these funnel
plots to administrative data from Dutch health care providers and demonstrate how they
may be used to follow up on unusual incidence rates. While funnel plots are well suited
for this purpose (VAN DISHOECK ET AL. 2011), they still require careful interpretation
(NEUBURGER ET AL. 2011, SEATON ET AL. 2013, MOHAMMED ET AL. 2013, SHAHIAN &
NORMAND 2015). The test does not provide definitive evidence of over- or undertreat-
ment, but is used as an indicator, the results of which are discussed with the hospitals
themselves.
2 METHODS
2.1 Data
The administrative data discussed in this article comprises all insurance claims made by
89 health care providers with one major health insurer in the Netherlands for the year
2013, involving 1,836,349 patients. Aggregate statistics on these claims were provided
by i2i — Intelligence to Integrity, a company that produces health care quality reports
for Dutch hospitals. Included were all providers categorized as regional, general, top-
clinical or academic. This excludes categorical hospitals and independent treatment cen-
tres, which treat a limited set of conditions. The claims are categorized by diagnosis –
2357 in total, divided over 29 medical specialities. Conforming to privacy regulations,
only aggregate statistics were obtained by the authors.
2.2 Funnel plots
Across hospitals, there is variation in the treatment of medical conditions. Examples of
treatment choices include whether to admit into hospital, whether to operate, and when
to discharge a patient. Much of this variation will exist for clinical reasons – that is, it will
occur “naturally” due to the distribution of patients and medical professionals. However,
there may also be exceptional deviations that cannot be explained clinically. An early
warning system for such exceptional deviations must therefore account for both natural
variation and the possibility of over- and undertreatment. We build such a system for the
Netherlands using funnel plots.
The funnel plot (SPIEGELHALTER 2005) is a type of control chart in which the control
limits account for both statistical and natural variation among the providers (OHLSSEN
ET AL. 2005). Control charts such as the funnel plot have been shown to lead to better
decision-making regarding the follow-up of unusual performance outcomes (MARSHALL
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ET AL. 2004b).
Our funnel plots are constructed on the incidence rates per diagnosis. When a provider
appears above or below the control limits it can be said to treat patients more or less read-
ily than other providers. However, this need not be absolute over- or undertreatment.
Firstly, the surplus or deficit may be relative, due to e.g. providers having different reg-
istration practices, attributing different diagnoses to similar patients. Secondly, we may
not want to call a surplus or deficit over- or undertreatment if it has an acceptable ex-
planation. In either case, it is still desirable to be able to identify the relevant providers.
However, it is clearly important to distinguish these cases from genuine over- and under-
treatment. This requires evaluation of the reason for a surplus or deficit by the hospital
itself. The Discussion further elaborates these points.
2.3 Setting control limits with random effects models
Per diagnosis and per provider i ∈ I, we define incidence as the number of patients oi
divided by the total number of potential patients ni, and compare this with the expected
number of patients ei based on casemix adjustment. Given these figures, funnel plots with
limits determined by random effects models provide us with a technique to determine
whether the incidence of a provider deviates from the range of ‘common cause’ variability
(SPIEGELHALTER 2005, OHLSSEN ET AL. 2005).
Following (OHLSSEN ET AL. 2005, pp. 868–70), we model the excess log-odds ratio of
becoming a patient,
yi := logit(oi/ni)− logit(ei/ni). (1)
This excess log-odds ratio is modelled using a normal approximation,
yi ∼ N (µi, si), (2)
where its standard deviation is taken to be estimated by si =
√
1/oi + 1/(ni − oi). After
the implicit casemix adjustment in Eq. 1, true hospital excesses γi may still vary due to a
number of small random factors, leading to a normal random effects model (MARSHALL
ET AL. 2004a),
µi ∼ N (µ, τ). (3)
For ease of computation from the very large database of claims, the parameters µ
and τ are estimated from the observed data yi using the method-of-moments estimator
(DERSIMONIAN & LAIRD 1986). We then create a funnel plot (SPIEGELHALTER 2005) by
plotting estimates of the true excess log-odds ratios,
µˆi = w∗i ∑
i∈I
yi/∑
i∈I
w∗i , (4)
where w∗i := (s
2
i + τˆ
2)−1, against the precision s−1i with funnel lines at
µˆ± c(s2i + τˆ2). (5)
where c is the number of standard deviations that one wants to consider. We choose c = 2
(2 sigma), corresponding to a 95% prediction limit.
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While we have access to the number oi of patients treated per provider i and per
diagnosis, there is no immediate way of knowing the number of non-patients, and, by
extension, the total number of potential patients ni. We estimate ni by distributing the
total number of people over those providers that have treated the diagnosis, according
to “market share”. This is determined on the basis of the total number of patients of the
speciality, and is adjusted for sex, age group, and socio-economic status.
3 RESULTS
The calculations as detailed in the previous section were run for all diagnoses. We il-
lustrate the results with six diagnoses that have been highlighted in the literature for
their variation (WENNBERG 1980, VAN SCHOOTEN ET AL. 2010). The first three diag-
noses exemplify less severe conditions that under some circumstances may not be serious
enough to warrant hospital treatment: (i) haemorrhoids, (ii) acute otitis media (AOM),
otitis media with effusion (OME), or Eustachian tube dysfunction, and (iii) nasal septum
deviations. The remaining three conditions are serious, especially when left untreated.
At the same time, the corresponding treatments may be high-risk and may not improve
quality of life for every patient. These are (iv) cataract, (v) prostate carcinoma, and (vi)
cholecystisis/cholelithiasis.
Figure 1 displays the resulting funnel plots for the less severe conditions. For all three
plots, most hospitals are within the control limits. However, for haemorrhoids and nasal
septum deviations, there are respectively two and one providers with unusually many
patients, even after adjusting for casemix and natural variation. For haemorrhoids and
AOM, OME, and Eustachian tube dysfunction, a number of hospitals have unusually few
patients.
The funnel plots in Figure 2 show similar patterns. For these conditions, there are
respectively four, two, and four hospitals with unusually few patients. Considering the
gravity of these conditions, follow-up may be needed. Towards the upper end of the plots,
we find respectively three, three and one providers with unusually many patients, which
may be justified, but could also indicate overtreatment. This, too, warrants investigation
by the relevant hospitals.
4 DISCUSSION
The results show that while hospitals vary with respect to patient numbers, in most cases
the variation is natural. Nonetheless, for each of the conditions examined, some providers
fall outside the control limits. Funnel plots constitute a useful tool for identifying hospi-
tals with higher or lower patient numbers requiring explanation. Scrutinizing these cases
is a first step towards reducing the costs and improving the quality of health care.
A strength of our method is that since it is based on administrative data, it can be
automated to apply across hospitals and diagnoses. Moreover, it is an objective test to
determine whether a hospital is really performing worse than other hospitals. As such,
it provides an alternative to simple ranking indicators, which may be misleading in as
much as the relative ranking is not statistically significant (LELEU ET AL. 2014).
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Figure 1: Funnel plots for three relatively light conditions. Top: haemorrhoids, middle:
AOM, OME, and Eustachian tube dysfunction, bottom: nasal septum deviations.
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Figure 2: Funnel plots for three serious conditions. Top: cataract, middle: prostate carci-
noma, bottom: cholecystisis/cholelithiasis.
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While it is possible to obtain initial results with funnel plots relatively easily, they
should not be used in isolation, because some providers may fall outside the control lim-
its for excellent reasons. Moreover, recent studies have emphasized the limitations of
relying solely on funnel plots to compare hospitals (NEUBURGER ET AL. 2011, SEATON
ET AL. 2013, MOHAMMED ET AL. 2013, SHAHIAN & NORMAND 2015). Outcome assess-
ment using funnel plots should therefore take place within a wider framework that gives
agency to health care providers. The results produced here were embedded into such
a system: feedback was given to participating providers allowing them to employ their
own expertise to make informed decisions. This was done as part of an ongoing pro-
cess where regular updates on the basis of new treatment figures enable the evaluation of
these decisions.
Interviews with doctors and hospital staff revealed a number of additional factors
that were fed back into the analysis as additional casemix adjustments. Closer inspec-
tion showed that certain apparent cases of absolute over- or undertreatment could be
explained as dispersion among hospitals or diagnoses. In a number of instances, similar
patients were attributed different diagnoses by different providers. In order to remove
this effect, the relevant diagnoses were combined. Another potential complication is that
a provider may be seen to undertreat if patients with certain conditions are drawn to a
specialized clinic that happens to be nearby, or conversely, to overtreat, if it itself provides
specific expertise. In some cases, it was possible to compensate for this by re-attributing
patients. A more radical solution would be to combine certain providers for specific con-
ditions in order to determine collective under- or overtreatment.
There are three main limitations to our study. First, we analysed data from only one
health insurer. While encompassing a large number of patients, it may be the case that
we missed some systematic variation across hospitals due to this selection. Future studies
might analyze data from all insurers or from a random sample of claims. Second, econom-
ical accounts such as (MCGUIRE 2000, Section 5) and ALGER & SALANIE´ 2006 identify
mechanisms that might engender general overtreatment by doctors. The argument that
there is a general tendency for overtreatment has also been made for specific conditions
such as thyroid cancer (LEE ET AL. 2012), for example due to the liberal application of
diagnostic tools. Such general over- (or under-)treatment occurring across all hospitals is
not detected by our method. Third, our approach is blind to under- and overtreatment
on an individual level, as for instance identified for asthma (CAUDRI ET AL. 2011), if this
cancels out at the hospital-level.
5 ACKNOWLEDGMENTS
We are grateful to Luca Schippa for assisting with the data preparation and to Michel Taal
for comments on the manuscript.
REFERENCES
ALBERS, LEAH L., 2005. Overtreatment of Normal Childbirth in U.S. Hospitals, Birth,
vol. 32, pp. 67–68.
7
ALGER, INGELA & FRANC¸OIS SALANIE´, 2006. A Theory of Fraud and Overtreatment in
Experts Markets, Journal of economics & management strategy, vol. 15, pp. 853–881.
BANGMA, CH, STIJN ROEMELING & FH SCHRO¨DER, 2007. Overdiagnosis and overtreat-
ment of early detected prostate cancer, World journal of urology, vol. 25, pp. 3–9.
BARDSLEY, M, DJ SPIEGELHALTER, I BLUNT, X CHITNIS, A ROBERTS & S BHARANIA,
2009. Using routine intelligence to target inspection of healthcare providers in England,
Quality & safety in health care, vol. 18, pp. 189–194.
BERWICK, DONALD M & ANDREW D HACKBARTH, 2012. Eliminating waste in US health
care, Journal of the American Medical Association, vol. 307, pp. 1513–1516.
BRATT, OLA, 2006. Watching the Face of Janus — Active Surveillance as a Strategy to
Reduce Overtreatment for Localised Prostate Cancer, European urology, vol. 50, pp. 410–
412.
CAUDRI, DAAN, ALET H. WIJGA, HENRIETTE A. SMIT, GERARD H. KOPPELMAN, MAR-
JAN KERKHOF, MAARTEN O. HOEKSTRA, BERT BRUNEKREEF & JOHAN C. DE JONG-
STE, 2011. Asthma symptoms and medication in the PIAMA birth cohort: Evidence for
under and overtreatment, Pediatric allergy and immunology, vol. 22, pp. 652–659.
COORY, MICHAEL, STEPHEN DUCKETT & KIRSTINE SKETCHER-BAKER, 2008. Using con-
trol charts to monitor quality of hospital care with administrative data, International
journal for quality in health care, vol. 20, pp. 31–39.
DERSIMONIAN, REBECCA & NAN LAIRD, 1986. Meta-analysis in clinical trials, Controlled
clinical trials, vol. 7, pp. 177–188.
VAN DISHOECK, A M, C W N LOOMAN, E C M VAN DER WILDEN-VAN LIER, J P MACK-
ENBACH & E W STEYERBERG, 2011. Displaying random variation in comparing hospi-
tal performance, BMJ quality & safety, vol. 20, pp. 651–657.
ESSERMAN, LAURA J, IAN M THOMPSON & BRIAN REID, 2013. Overdiagnosis and
overtreatment in cancer: an opportunity for improvement, Journal of the American Med-
ical Association, vol. 310, pp. 797–798.
FRANKS, PETER, CAROLYN M CLANCY & PAUL A NUTTING, 1992. Gatekeeping
revisited–protecting patients from overtreatment, The New England journal of medicine,
vol. 327, p. 424.
FURBERG, C. D., G. BERGLUND, T. A. MANOLIO & B. M. PSATY, 1994. Overtreatment
and undertreatment of hypertension, Journal of internal medicine, vol. 235, pp. 187–197.
HEIJNSDIJK, E A M, A DER KINDEREN, E M WEVER, G DRAISMA, M J ROOBOL & H J
DE KONING, 2009. Overdetection, overtreatment and costs in prostate-specific antigen
screening for prostate cancer, British journal of cancer, vol. 101, pp. 1833–1838.
8
JARMAN, B, D PIETER, AA VAN DER VEEN, RB KOOL, P AYLIN, A BOTTLE, GP WESTERT
& S JONES, 2010. The hospital standardised mortality ratio: a powerful tool for Dutch
hospitals to assess their quality of care?, Quality & safety in health care, vol. 19, pp. 9–13.
LEE, TAE-JIN, SUN KIM, HONG-JUN CHO & JAE-HO LEE, 2012. The Incidence of Thy-
roid Cancer Is Affected by the Characteristics of a Healthcare System, Journal of Korean
medical science, vol. 27, pp. 1491–1498.
LELEU, HENRI, FRE´DE´RIC CAPUANO, GE´RARD NITENBERG, LYDIE TRAVENTAL & ETI-
ENNE MINVIELLE, 2014. Hospital performance based on treatment delays: comparison
of ranking methods, BMJ quality & safety, vol. 23, pp. 73–77.
MARSHALL, CLARE, NICKY BEST, ALEX BOTTLE & PAUL AYLIN, 2004a. Statistical issues
in the prospective monitoring of health outcomes across multiple units, Journal of the
Royal Statistical Society: Series A (Statistics in Society), vol. 167, pp. 541–559.
MARSHALL, TOM, MOHAMMED A MOHAMMED & ANDREW ROUSE, 2004b. A random-
ized controlled trial of league tables and control charts as aids to health service decision-
making, International journal for quality in health care, vol. 16, pp. 309–315.
MCGUIRE, T. G., 2000. Physician Agency, in Anthony J. Culyer & Joseph P. Newhouse
(eds.), Handbook of Health Economics, Volume 1A, Handbooks in Economics, chap. 9, pp.
461–536 (Elsevier, Amsterdam).
MOHAMMED, MOHAMMED A, JAGDEEP S PANESAR, DAVID B LANEY & RICHARD WIL-
SON, 2013. Statistical process control charts for attribute data involving very large sam-
ple sizes: a review of problems and solutions, BMJ quality & safety, vol. 22, pp. 362–368.
NEUBURGER, JENNY, DAVID A CROMWELL, ANDREW HUTCHINGS, NICK BLACK &
JAN H VAN DER MEULEN, 2011. Funnel plots for comparing provider performance
based on patient-reported outcome measures, BMJ quality & safety, vol. 20, pp. 1020–
1026.
OHLSSEN, DAVID I., LINDA D. SHARPLES & DAVID J. SPIEGELHALTER, 2005. A hierarchi-
cal modelling framework for identifying unusual performance in health care providers,
Journal of the Royal Statistical Society: Series A (Statistics in Society), vol. 170, pp. 865 – 890.
VAN SCHOOTEN, GWENDY, LINDE JACOBS, NICOLINE BEERSEN
& MARC BERG, 2010. Praktijkvariatie rond indicatiestelling in
Nederlandse ziekenhuizen. URL http://www.kpmg.com/NL/nl/
IssuesAndInsights/ArticlesPublications/Documents/PDF/Healthcare/
Praktijkvariatie-rond-indicatiestelling-in-Nederlandse-ziekenhuizen.pdf,
advisory report for Zichtbare Zorg Ziekenhuizen.
SEATON, SARAH E, LISA BARKER, HESTER F LINGSMA, EWOUT W STEYERBERG &
BRADLEY N MANKTELOW, 2013. What is the probability of detecting poorly perform-
ing hospitals using funnel plots?, BMJ quality & safety, vol. 22, pp. 870–876.
9
SHAHIAN, DAVID M & SHARON-LISE T NORMAND, 2015. What is a performance outlier?,
BMJ quality & safety, vol. 24, pp. 95–99.
SPIEGELHALTER, DAVID J., 2005. Funnel plots for comparing institutional performance,
Statistics in medicine, vol. 24, pp. 1185 – 1202.
SUTIN, DAVID G., 2010. Diabetes mellitus in older adults: time for an overtreatment qual-
ity indicator, Journal of the American Geriatrics Society, vol. 58, pp. 2244–2245.
WENNBERG, JOHN E., 1980. The Need for Assessing the Outcome of Common Medical
Practices, Annual review of public health, vol. 1, pp. 277 – 295.
10
